Design and Synthesis of Some New 1,4-Benzoxazine-Isoxazole Hybrids as In Vitro Anticancer Agents

[1]  A. R. Bohórquez,et al.  Synthesis and in vitro evaluation of substituted tetrahydroquinoline-isoxazole hybrids as anticancer agents , 2019, Medicinal Chemistry Research.

[2]  R. Kancha,et al.  Synthesis of novel forskolin isoxazole derivatives with potent anti-cancer activity against breast cancer cell lines. , 2017, Bioorganic & medicinal chemistry letters.

[3]  Y. Reddy,et al.  One-pot synthesis of fused benzoxazino[1,2,3]triazolyl[4,5-c]quinolinone derivatives and their anticancer activity , 2016 .

[4]  A. Gangagni Rao,et al.  Synthesis of novel triazole/isoxazole functionalized 7-(trifluoromethyl)pyrido[2,3-d]pyrimidine derivatives as promising anticancer and antibacterial agents. , 2016, Bioorganic & medicinal chemistry letters.

[5]  N. Jain,et al.  Rational design, synthesis and anti-proliferative evaluation of novel 1,4-benzoxazine-[1,2,3]triazole hybrids. , 2015, European journal of medicinal chemistry.

[6]  Canzhong Lu,et al.  Potential anticancer agents. I. Synthesis of isoxazole moiety containing quinazoline derivatives and preliminarily in vitro anticancer activity. , 2014, Anti-cancer agents in medicinal chemistry.

[7]  E. Rajanarendar,et al.  Multi-component synthesis and in vitro and in vivo anticancer activity of novel arylmethylene bis-isoxazolo[4,5-b]pyridine-N-oxides. , 2012, European journal of medicinal chemistry.

[8]  V. Fokin,et al.  One-pot copper(I)-catalyzed synthesis of 3,5-disubstituted isoxazoles. , 2005, The Journal of organic chemistry.